1) De Ruysscher, D., et al.: Time between the first day of chemotherapy and the last day of chest radiation is the most important predictor of survival in limited-disease small-cell lung cancer. J. Clin. Oncol., 24, 1057-1063 (2006)
3) Pignon, J. P., et al.: Lung adjuvant cisplatin evaluation: a pooled analysis by the LACE Collaborative Group. J. Clin. Oncol., 26, 3552-3559 (2008)
4) Kato, H., et al.: A randomized trial of adjuvant chemotherapy with tegafur-uracil in non-small-cell lung cancer. N. Engl. J. Med., 350, 1713-1721 (2004)